June 3, 2020
NodThera Announces Close of $55 Million Series B Financing
NodThera has secured $55 million (£44 million) in a Series B financing. NodThera’s lead candidate, NT-0167, is being evaluated in a Phase 1 clinical trial in healthy volunteers.